Christine Cassiano | Chief Communications Officer |
David Chang | Co-Founder, President, CEO & Director |
Zachary Roberts | EVP, Research & Development |
Eric Schmidt | CFO |
Jenna Li | Jefferies |
Tyler Van Buren | Cowen and Company |
Brian Cheng | JPMorgan Chase & Co. |
Charles Butler | EF Hutton |
John Newman | Canaccord Genuity |
David Dai | SMBC |
Mark Breidenbach | Oppenheimer |
Jason Gerberry | Bank of America Merrill Lynch |
Reni Benjamin | JMP Securities |
Luca Issi | RBC Capital Markets |
Paul Jeng | Guggenheim Securities |
Raju Prasad | William Blair & Company |
Jack Allen | Robert W. Baird & Co. |
Asthika Goonewardene | Truist Securities |
Kalpit Patel | B. Riley Securities |
Good day, ladies and gentlemen, and thank you for standing by. Welcome to Allogene Therapeutics' Fourth Quarter and Year-End 2022 Earnings Conference Call. [Operator Instructions].
I would now like to turn the call over to Christine Cassiano, Chief Communications Officer. Ms.